Fast-Tracked DNA-Based Therapeutic Cancer Vaccine to Be Given to Melanoma Patients in U.K.
Patients in England with advanced skin melanoma are receiving a “revolutionary” new therapeutic cancer vaccine in a National Health Service (NHS) clinical trial that is being used to fast-track the biological to licensure. The vaccine, iSCIB1+—also known as ImmunoBody—is a DNA-based treatment designed to boost the immune system’s ability to target and remember melanoma cells.1 […]
Novel Breast Cancer Vaccine Technology Receives Japanese Patent
Anixa Biosciences, Inc. of San Jose, California announced on July 17, 2024, that its collaborator, the Cleveland Clinic, has received a “Decision to Grant” notice from the Japan Patent Office (JPO) for the patent application titled “Vaccine Adjuvants and Formulations” for its novel breast cancer vaccine technology. The company is two decades into developing a […]